Introduction
============

The growth and development of the prostate is regulated by hormones. Abnormal hormonal secretions lead to prostatic lesions, including benign prostatic hyperplasia (BPH). A previous study by Alonso-Magdalena *et al* ([@b1-ol-0-0-6469]) reported that BPH is not a disease of prostatic stromal proliferation, but of the accumulation of mesenchymal-like cells derived from the prostatic epithelium and endothelium. Therefore, the proliferation of epithelial cells in the hyperplastic acini is indispensable for benign growth of the prostate gland.

Bisphenol A (BPA), a xenoestrogen, is a key monomer and industrial plasticizer, fungicide, flame retardant and component of epoxy resins used in food packaging, including cans and metal jar lids ([@b2-ol-0-0-6469],[@b3-ol-0-0-6469]). In humans, data from previous studies suggests that BPA may induce adverse outcomes and medical conditions, particularly on the reproductive and metabolic systems. However, the majority of these studies examine non-occupationally exposed people, who may be considered 'low dose', and thus these studies support the hypothesis that average levels of BPA exposure is sufficient to cause toxicity and affect human health ([@b4-ol-0-0-6469]). 'Low dose' has become a widely used term referring to toxicity studies for BPA that has been considered more informative about the potential health risk in humans compared with higher exposure studies ([@b5-ol-0-0-6469]). There are numerous animal studies demonstrating causal associations between BPA exposure and harm.

As an endocrine disruptor, BPA stimulates cellular responses at low concentrations, below the levels where BPA is expected to bind to classical nuclear estrogen receptors (ERs). For example, BPA altered the differentiation pattern of periductal stromal cells of the ventral prostate by diminishing the expression of androgen receptors (AR) andprostatic acid phosphatase (PAP) ([@b6-ol-0-0-6469]). Additionally, studies have demonstrated that BPA induces PCa cell migration via the modulation of the ion channel protein expression involved in calcium entry and in cancer cell migration ([@b7-ol-0-0-6469]). In addition to the adverse effect *in vitro*, BPA is known to affect prostate weight in rats ([@b8-ol-0-0-6469],[@b9-ol-0-0-6469]) and elicit cytokeratin 10 expression in the prostatic epithelium of mice ([@b10-ol-0-0-6469]). The administration of 10 µg/kg BPA to Sprague-Dawley (SD) rats on days 1, 3 and 5 markedly increased the incidence of adult estrogen-induced prostate intraepithelial neoplasia compared with control rats ([@b11-ol-0-0-6469]). We have previously demonstrated that environmental exposure to a low daily dose, 10 µg/kg intragastric, of BPA may induce proliferation of the ventral prostate in adult rats by increasing the estrogen to androgen ratio and upregulating the expression of prostaglandin D2 synthase to promote the production of dihydrotestosterone ([@b12-ol-0-0-6469]). However, a direct association between low dose BPA and alterations to the prostatic epithelium has not been investigated.

Based on the aforementioned evidence, it is hypothesized that environmental exposure to BPA may promote the proliferation of prostate cells in the ventral prostate. In the present study, the possible mechanisms of action and the direct proliferative influence of BPA on primary cultured prostatic epithelium in rats were examined.

Materials and methods
=====================

### Ethical standards

All animals in the present study were treated humanely according to the Guide for the Care and Use of Laboratory Animals of the Shanghai Institute of Planned Parenthood Research Animal Care and Use Committee (Shanghai, China).

### Animals and housing

Male SD rats aged 10 weeks and weighing 240 g were purchased from Sino-British SIPPR/BK Laboratory Animal Co., Ltd., Shanghai, China. The animals were housed on sawdust bedding in standard polypropylene cages. Drinking water and a pellet diet (Shanghai Shilin Science & Tech Co., Ltd, China) were available *ad libitum* in glass bottles. The rooms were maintained at temperatures between 20 and 26°C and 40--70% humidity under a 12:12 h light: dark cycle. Animals were anesthetized with pentobarbital sodium following 5 days of adaptive breeding. All animal procedures were approved by the Animal Care and Use Committee of Shanghai Institute of Planned Parenthood Research (Shanghai, China), and conformed to the Guide for the Care and Use of Laboratory Animals ([@b13-ol-0-0-6469]).

### Reagents

BPA (lot no., 162k0715; purity, 95%) and collagenase II were purchased from Sigma-Aldrich; Epidermal growth factor and cholera toxin were purchased from Merck KGaA (Darmstadt, Germany). Insulin and transferrin were purchased from R&D Systems China Co., Ltd. (Shanghai, China). The RPMI-1640 medium (without phenol red, with glutamine) was from Gibco; Thermo Fisher Scientific, Inc. (Waltham, MA, USA). RPMI-1640 medium (with glutamine) was supplied by Hyclone; GE Healthcare Sciences (Logan, UT, USA). Fetal bovine serum (FBS) was sourced from Hangzhou Sijiqing Biological Engineering Materials Co., Ltd. (Hangzhou, China). Mouse anti-pan cytokeratin (cat. no. BM0034), rabbit anti-androgen receptor (cat. no. BA0004), rabbit anti-ERα (cat. no. BA0345), rabbit anti-ERβ (cat. no. BA2210), StreptAvidin Biotin peroxidase Complex (SABC; SA1022) kit, and 3′3 diaminobenzidine (DAB; cat. no. AR1022) kit were purchased from Wuhan Boster Biological Technology, Ltd. (Wuhan, China). Dimethyl sulphoxide (DMSO) was sourced from Shanghai Shisheng Cell Biology Technology Co., Ltd. (Shanghai, China). Cell Counting Kit-8 (CCK-8) was purchased from Dojindo Molecular Technologies (Kumamoto, Japan). Annexin V-fluorescein isothiocyante (FITC), propidium iodide (PI) and 5X binding buffer were purchased from Merck & Co., Inc. (Whitehouse Station, NJ, USA).

### Cell culture

As described previously ([@b14-ol-0-0-6469]), the ventral prostates were removed, weighed and cut into 1.0-mm^3^ blocks. Subsequent to the addition of 675 U/ml collagenase II, the tissue suspension was blown 3 times with a straw and incubated at 37°C for 1 h. The suspension was then cooled to 4°C and looped through 200-, 300- and 400-mesh sieves to obtain individual cells. The cells were collected subsequent to centrifugation at 4°C at 1,500 x g for 5 min, and dispersed in RPMI-1640 at a concentration of 5×105 cells/ml. The cells were seeded in RPMI-1640 culture medium supplemented with 10% FBS, 100 µg/ml penicillin, 100 U/ml streptomycin, 10 µg/l epidermal growth factor, 10 µg/l cholera toxin, 5 mg/l transferrin and 5 mg/l insulin, and cultured at 37°C with 5% CO~2~, changing the culture medium every 3--5 days.

### Cell identification

The cells were dispersed at a density of 1×105/ml and seeded in 12-well plates for culturing. The medium was removed subsequent to 12 days of adherent growth. The slides were fixed with 10% formalin for 60 min and endogenous peroxidase was quenched with hydrogen peroxide in methanol solution (fresh, 30% H~2~O~2~; methyl alcohol; dilution, 1:50) for 30 min. The cells were washed with distilled water and immersed in 5% bovine serum albumin for 20 min at room temperature to block the non-specific binding sites prior to incubation with mouse anti-pan cytokeratin (dilution, 1:100) in a wet box at 4°C overnight. Biotin-labeled goat anti-rabbit IgG (contained within the SABC kit; ready-to-use) and SABC kit were added successively at 37°C for 20 min, followed by staining with a DAB kit. The sections were counterstained with hematoxylin and dehydrated, washed, mounted and observed under a Motic inverted microscope.

### Treatment

Theprostatic epithelium suspension was seeded in 96-well plates and 24-well plates, and each hole was filled with 200 µl suspension. The culture medium was replaced every 3 days. Subsequent to 12 days cultivation, the culture medium was substituted with phenol red-free RPMI-1640 without serum, and BPA was added to make a final concentration of 0.01, 0.1, 1, 10, 100 and 1000 nM. This solution was maintained for 72 h, subsequently the cells were processed for subsequent experiments. DMSO was used as the control, and the final concentration of the solution was below 0.5%.

### Cell morphological analysis by Giemsa

The medium of prostatic epithelium inoculated in 24-well plates was discarded subsequent to treatment. The plates were then washed twice with physiological saline prior to fixation with 95% ethanol for 30 min and staining with Giemsa for 15 min. The reactions were halted with water and the images were captured with a Motic inverted microscope.

### Cell viability assay by CCK-8

The supernatant of prostatic epithelium inoculated in the 96-well plates was discarded, and the cell viability was detected by the WST-8 assay with CCK-8, according to the protocol of the manufacturer. Absorbance was measured at 450 nm using a microplate reader. The cell viability was calculated using the formula: Cell viability (%) = \[(the experimental value-the blank value) / (the control value-the blank value)\] x100. A cell viability chart was then drawn.

### Detection of apoptosis by flow cytometry

Subsequent to producing the cell viability chart, the proliferation mechanism of BPA on prostate epithelial cells was investigated. The cells were treated with 0.01, 0.1 and 1 nM BPA for 72 h, respectively, and the prostatic epithelia were then digested to obtain single cells at a density of 1×106/ml and centrifuged at 4°C and 1,500 x g for 5 min. The supernatant was discarded and the cells were washed with the binding buffer, centrifuged (4°C, 1,500 x g) and incubated with 100 µl Annexin V-FITC for 10 min at room temperature. Washing and centrifugation (4°C, 1,500 x g) were repeated, followed by the addition of PI. The mixture was incubated for 20 min at 4°C, and cell apoptosis was detected by flow cytometry (FACSCalibur™, BD Biosciences, Franklin Lakes, NJ, USA).

### Evaluation of AR and ER expression by immunocytochemistry analysis

The cells were dispersed at a density of 1×105/ml and seeded in 12-well plates for culturing. The medium was removed subsequent to 12 days of adherent growth. The slides were fixed with 10% formalin for 60 min and endogenous peroxidase was quenched with hydrogen peroxide in methanol solution (fresh, 30% H~2~O~2~; methyl alcohol, dilution, 1:50) for 30 min. The cells were washed with distilled water and immersed in 5% bovine serum albumin for 20 min at room temperature to block the non-specific binding sites prior to incubation with the anti-androgen receptor, anti-ERα and anti-ERβ primary antibodies (dilution, 1:100) in a wet box at 4°C overnight. Biotin-labeled Goat Anti-Rabbit IgG and SABC were added successively at 37°C for 20 min, followed by staining with a DAB kit. The sections were counterstained with hematoxylin and dehydrated, washed, mounted, and observed under a Motic inverted microscope. Finally, 120 cells in each group were randomly selected to obtain the mean values with the Motic Images Advanced 3.2 software (Motic, Kowloon, Hong Kong).

### Statistical analysis

Data were analyzed using SPSS version 11.0 (SPSS, Inc., Chicago, IL, USA) and expressed as the mean ± standard deviation of three experimental repeats. Statistical comparisons were performed by one-factor analysis of variance. If statistically significant, the differences between control and treatment groups were tested by the least-squares means test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Cell morphological analysis

Giemsa staining revealed that the cultured cells were flattened and polygonal, the nucleus was approximately oval and located in the center of the cytoplasm and the cells were closely linked and appeared to grow in clusters. All these features conformed to the features of epithelial cells ([Fig. 1](#f1-ol-0-0-6469){ref-type="fig"}). Subsequent to treatment of the prostatic epithelium with 0.01--1,000 nM BPA for 72 h, no marked changes in cell morphology were observed compared with the control group ([Fig. 2](#f2-ol-0-0-6469){ref-type="fig"}).

### Cell viability

The cells were exposed to 0.01--1,000 nM BPA, and cell viability was tested by the CCK-8 method. At doses of 0.01--1 nM BPA, the cells exhibited growth-promoting activity and the cell survival rate increased as BPA dose increased. In the cells exposed to a dose of BPA \>1 nM, there was less growth promotion, and there was growth-nhibition with the dose of 1,000 nM, as presented in [Fig. 3](#f3-ol-0-0-6469){ref-type="fig"}.

### Cell apoptosis

In Annexin V-FITC/PI double staining, the apoptotic cells resisted staining by PI, whilst the necrotic cells did not. All DNA with damaged membranes were dyed fluorescent red by PI, whilst the cells with intact membranes were not dyed. Therefore, these cells did not emit a red fluorescence signal in the early stages of apoptosis, which was exhibited by the normal living cells. These results demonstrated that the apoptosis rate in 0.01--1 nM BPA-treated groups was lower, and the quantity of living cells was higher compared with in the control group, which was consistent with the trends in cell viability, as summarized in [Table I](#tI-ol-0-0-6469){ref-type="table"}.

### Expressions of AR and ER in prostate epithelial cells

Immunocytochemistry analysis revealed that a 0.01--1 nM dose of BPA downregulated the expression of AR (P\<0.01), and this inhibition increased with increasing doses of BPA. Simultaneously, BPA upregulated the expression of ERα and ERβ (P\<0.01), and the expression of ERβ increased with increasing dose of BPA, while the expression of ERα decreased slightly, as illustrated in [Figs. 4](#f4-ol-0-0-6469){ref-type="fig"}--[7](#f7-ol-0-0-6469){ref-type="fig"}.

Discussion
==========

The exposure to low doses of BPA, an endocrine disruptor, has been demonstrated to induce proliferation of the prostate and aggravation of testosterone-induced BPH in rats, by affecting the prostatic epithelium of the ventral prostate ([@b15-ol-0-0-6469]). In the present study, prostate epithelial cells were cultured successfully. Prostatic epithelial cells of rats in a primary cultured system were established smoothly under the experimental conditions, which permitted additional investigation into the pathogenesis of BPH and the mechanism of action of BPA.

Similar to hormones, EDCs are generally reported to demonstrate a bi-phasic dose response as they are stimulating at low doses and inhibiting at high doses. U-shaped or inverted U-shaped non-monotonic dose-response curves are used to demonstrate this effect. For example, Gualtieri *et al* ([@b16-ol-0-0-6469]) used Sertoli cells exposed to series of doses, 0.5 nM-100 µM, of BPA, to demonstrate that only intermediate doses, 10--50 µM, enhanced cell viability through increasing the levels of cell-protecting glutathione. In the present study, cell viability testing by the CCK-8 method revealed that BPA elicited bi-phasic dose responses, as 0.01--1 nM BPA promoted cell growth, but 10--1,000 nM elicited growth inhibition. The inverse U-shape dose-response curve maybe more marked if the dose interval was diminished. However, the present study focused on the effect of BPA treatment on cell proliferation activity, because it was more applicable. A dose of 1 nM BPA was equivalent to the BPA detected in serum in environmental exposures ([@b17-ol-0-0-6469]), which suggests that BPA may promote prostate cell growth directly at an environmental level. This result was consistent with another study that revealed that 1 nM BPA promoted the hyperplasia of testosterone-dependent prostate cancer cells ([@b18-ol-0-0-6469]).

Although BPA has been reported to be involved in apoptosis of numerous types of cells, the exposure dose and cell lines may be important factors in how the chemical affects apoptosis. For instance, 100 µg/ml BPA caused comparable apoptosis by increasing cytosolic Ca^2+^ level, reducing the transmembrane mitochondrial potential, increasing caspase −8, −9, −3 activities and poly (ADP-ribose) Polymerase-1 cleavage in peripheral blood mononuclear cells ([@b19-ol-0-0-6469]). Zhou *at al* ([@b20-ol-0-0-6469]) revealed that *in vitro* 0.1, 1, 5 and 10 µg/ml BPA exposure significantly inhibited germ cell nest breakdown by altering the expression of key ovarian apoptotic genes. BPA appears to inhibit apoptosis at low doses but promotes apoptosis at high doses, which conforms to the effect on cell viability. The present study demonstrated that inhibition of apoptosis was observed in the prostate epithelial cells exposed to 0.01--1 nM BPA, whilst BPA doses of \>1 nM may only exhibit slight cytotoxic effects ([@b21-ol-0-0-6469]). Therefore, apoptosis may participate in the effects of BPA on the prostate within an appropriate range of exposures.

BPA is considered to exhibit weak estrogenic activity based on the relative binding affinity of the compound for nuclear receptors ERα and ERβ, which is \~1,000-10,000 times less than the affinity of the compound for estradiol ([@b22-ol-0-0-6469]). ERα exists in the nucleus and is distributed mainly in the prostatic stroma; it may be detected in the epithelium subsequent to exposure to estrogen. ERβ is a member of the estrogen receptor family and the nuclear receptor superfamily ([@b23-ol-0-0-6469]). ERα and ERβ may be involved in the regulation of transcription ([@b24-ol-0-0-6469]). Generally, ERα promotes the hyperplasia of prostatic epithelial cells, whilst ERβ possesses anti-proliferative effects ([@b25-ol-0-0-6469]), which contributes to the maintenance of a dynamic balance between promoting and inhibiting cell growth. BPA combines with ER ([@b26-ol-0-0-6469],[@b27-ol-0-0-6469]), and the responses of ERα and ERβ to BPA differ as BPA binds to ERα with a lesser affinity compared with ERβ. In the present study, a combination of BPA and ER led to an increase in the level of ER expression, which correspondingly promoted cell proliferation and inhibition. However, the greatest effect was exhibited in the rates of cell proliferation in the cells treated with lower doses, 0.01--1 nM, of BPA. Conversely, with the dose increasing, the inhibition may enhance. In addition to binding to ERs, BPA exposure has been demonstrated to interfere with the thyroid hormone pathway by binding to thyroid hormone receptor ([@b28-ol-0-0-6469]).

The prostate is an androgen-dependent organ, and AR serves a pivotal role in regulating the function, growth and differentiation of the prostate gland. In the present study, it was revealed that 0.01--1 nM BPA reduced the expression of AR. BPA exhibits strong antiandrogenic activity, both *in vitro* and *in vivo*, with a lower affinity for AR compared with ER ([@b29-ol-0-0-6469],[@b30-ol-0-0-6469]). The AR is a ligand-activated transcription factor and binds to specific elements of the androgen response on target genes to stimulate transcription ([@b31-ol-0-0-6469]), but this activity is effectively ablated by BPA, leading to the disruption of transcription and androgen-independent prostate cancer cell proliferation ([@b32-ol-0-0-6469]). Environmental exposures to low doses of BPA activated a mutated AR and promoted testosterone-dependent cell proliferation, and that BPA acts as a ligand for the AR mutant and stimulates cell proliferation at doses of ≤1 nM ([@b18-ol-0-0-6469]). However, there is a debate concerning whether upregulated or downregulated expression of AR is important. The weak estrogenic and antiandrogenic activity of BPA possibly results in an imbalance of estrogen and androgen, leading to an overall increase in the relative levels of estradiol, which is considered a factor leading to the development of BPH ([@b33-ol-0-0-6469]).

In conclusion, the present study suggests that environmental exposure to BPA directly promoted the proliferation of prostate cells, and that this effect may have been achieved by downregulating the expression of AR and upregulating the expression of ER in cells, inhibiting cell apoptosis. However, the complicated crosstalk amongst different signaling pathways of BPA on the prostate and the possible mechanisms by which BPA activates ER and antagonizes AR functions, alongside the pathways that are involved in apoptosis require future investigation.
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![Primary cultured prostatic epithelium in rat. (A) Normal prostatic epithelium at magnification, x100. (B) Normal prostatic epithelium at x200 magnification. Bar represents 100 µm.](ol-14-03-2635-g00){#f1-ol-0-0-6469}

![Effect of BPA on primary cultured prostatic epithelial cells. (A) Vehicle control. (B) 0.01 nM BPA. (C) 0.1 nM BPA. (D) 1 nM BPA. (E) 10 nM BPA. (F) 100 nM BPA. (G) 1000 nM BPA. All images at x200 magnification. Bar represents 100 µm. BPA, Bisphenol A.](ol-14-03-2635-g01){#f2-ol-0-0-6469}

![Effect of BPA on the growth rate of prostate epithelial cells. Bars represent the standard deviation. \*P\<0.05, \*\*P\<0.01 compared with the vehicle controls. BPA, Bisphenol A.](ol-14-03-2635-g02){#f3-ol-0-0-6469}

![Effect of BPA on androgen receptor expression of primary cultured prostatic epithelial cells. (A) Vehicle control group (B) 0.01 nM BPA. (C) 0.1 nM BPA. (D) 1 nM BPA. All images at x200 magnification. Bar represents 100 µm. BPA, Bisphenol A.](ol-14-03-2635-g03){#f4-ol-0-0-6469}

![Effect of BPA on estrogen receptor α expression of primary cultured prostatic epithelial cells. (A) Vehicle control group. (B) 0.01 nM BPA. (C) 0.1 nM BPA. (D) 1 nM BPA. All images at x200 magnification. Bar represents 100 µm. BPA, Bisphenol A.](ol-14-03-2635-g04){#f5-ol-0-0-6469}

![Effect of BPA on estrogen receptor β expression of primary cultured prostatic epithelial cells. (A) Vehicle control. (B) 0.01 nM BPA. (C) 0.1 nM BPA. (D) 1 nM BPA. All images at x200 magnification. Bar represents 100 µm. BPA, Bisphenol A.](ol-14-03-2635-g05){#f6-ol-0-0-6469}

![Effect of BPA on the expressions of AR, ERα and ERβ of primary cultured prostatic epithelial cells. n=120. \*P\<0.05 vs. control group. \*\*P\<0.01 vs. control group. AR, androgen receptor; ERα, estrogen receptor α; ERβ, estrogen receptor βl; BPA, Bisphenol A.](ol-14-03-2635-g06){#f7-ol-0-0-6469}

###### 

Effects of BPA on the apoptosis of prostate epithelial cells.

  Dose (nM)                 Necrotic (%)   Living cells (%)                                     Apoptotic cells (%)
  ------------------------- -------------- ---------------------------------------------------- ---------------------
  Control                   3.15           89.64                                                4.87
  BPA (0.01)                0.70           96.14^[a](#tfn1-ol-0-0-6469){ref-type="table-fn"}^     2.72a
  BPA (0.1)                 1.86           94.09^[a](#tfn1-ol-0-0-6469){ref-type="table-fn"}^     2.53a
  BPA ([@b1-ol-0-0-6469])   1.14           93.92^[a](#tfn1-ol-0-0-6469){ref-type="table-fn"}^     2.77a

P\<0.01 vs. control group.
